Ubs Group Ag Cor Medix Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Cor Medix Inc. stock. As of the latest transaction made, Ubs Group Ag holds 39,516 shares of CRMD stock, worth $408,200. This represents 0.0% of its overall portfolio holdings.

Number of Shares

39,516

Previous 36,819 7.33%

Holding current value

$408,200

Previous $159,000 100.63%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.64 - $8.23 $9,817 - $22,196	2,697 Added 7.33%	39,516 $319,000
Q2 2024 Aug 13, 2024	SELL	$4.08 - $6.39 $102,338 - $160,280	-25,083 Reduced 40.52%	36,819 $159,000
Q1 2024 May 13, 2024	SELL	$2.94 - $4.24 $7,264 - $10,477	-2,471 Reduced 3.84%	61,902 $262,000
Q4 2023 Feb 09, 2024	BUY	$3.0 - $4.01 $100,170 - $133,893	33,390 Added 107.77%	64,373 $242,000
Q3 2023 Nov 09, 2023	SELL	$3.6 - $4.46 $36,954 - $45,781	-10,265 Reduced 24.89%	30,983 $114,000
Q2 2023 Aug 11, 2023	BUY	$3.94 - $5.8 $151,229 - $222,621	38,383 Added 1339.72%	41,248 $163,000
Q1 2023 May 12, 2023	BUY	$3.22 - $4.61 $6,233 - $8,924	1,936 Added 208.4%	2,865 $11,000
Q4 2022 Feb 08, 2023	SELL	$2.81 - $4.45 $18,860 - $29,868	-6,712 Reduced 87.84%	929 $3,000
Q3 2022 Nov 10, 2022	BUY	$2.82 - $7.52 $21,547 - $57,460	7,641 New	7,641 $22,000
Q2 2022 Aug 10, 2022	SELL	$2.73 - $5.61 $27,843 - $57,216	-10,199 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$3.83 - $6.24 $31,057 - $50,600	-8,109 Reduced 44.29%	10,199 $56,000
Q4 2021 Feb 14, 2022	BUY	$4.47 - $5.56 $60,716 - $75,521	13,583 Added 287.47%	18,308 $83,000
Q3 2021 Nov 15, 2021	BUY	$4.46 - $7.11 $16,725 - $26,662	3,750 Added 384.62%	4,725 $22,000
Q2 2021 Aug 13, 2021	SELL	$6.05 - $10.09 $52,628 - $87,772	-8,699 Reduced 89.92%	975 $7,000
Q1 2021 May 12, 2021	BUY	$6.84 - $17.58 $16,183 - $41,594	2,366 Added 32.38%	9,674 $97,000
Q4 2020 Feb 11, 2021	BUY	$5.0 - $9.15 $16,425 - $30,057	3,285 Added 81.66%	7,308 $54,000
Q3 2020 Nov 12, 2020	SELL	$3.96 - $6.15 $23,783 - $36,936	-6,006 Reduced 59.89%	4,023 $24,000
Q2 2020 Jul 31, 2020	SELL	$3.08 - $6.56 $16,373 - $34,872	-5,316 Reduced 34.64%	10,029 $63,000
Q1 2020 May 01, 2020	SELL	$2.35 - $7.08 $38,314 - $115,432	-16,304 Reduced 51.52%	15,345 $55,000
Q4 2019 Feb 14, 2020	BUY	$4.96 - $7.75 $66,548 - $103,981	13,417 Added 73.59%	31,649 $230,000
Q3 2019 Nov 14, 2019	BUY	$6.38 - $9.69 $77,134 - $117,152	12,090 Added 196.84%	18,232 $116,000
Q2 2019 Aug 14, 2019	BUY	$5.93 - $10.57 $29,359 - $52,332	4,951 Added 415.7%	6,142 $55,000
Q1 2019 May 14, 2019	BUY	$6.95 - $13.25 $8,277 - $15,780	1,191 New	1,191 $11,000

Others Institutions Holding CRMD

# of Institutions

104

Shares Held

17.4M

Call Options Held

134K

Put Options Held

441K

View Full List

About CorMedix Inc.

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $426M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

More about CRMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account